annual current liabilities:
$179.67M+$77.00M(+74.99%)Summary
- As of today (June 21, 2025), CYTK annual total current liabilities is $179.67 million, with the most recent change of +$77.00 million (+74.99%) on December 31, 2024.
- During the last 3 years, CYTK annual current liabilities has risen by +$107.81 million (+150.03%).
- CYTK annual current liabilities is now at all-time high.
Performance
CYTK Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$159.73M-$19.95M(-11.10%)Summary
- As of today (June 21, 2025), CYTK quarterly total current liabilities is $159.73 million, with the most recent change of -$19.95 million (-11.10%) on March 1, 2025.
- Over the past year, CYTK quarterly current liabilities has increased by +$70.87 million (+79.76%).
- CYTK quarterly current liabilities is now -11.10% below its all-time high of $179.67 million, reached on December 31, 2024.
Performance
CYTK quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
CYTK Current liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +75.0% | +79.8% |
3 y3 years | +150.0% | +138.9% |
5 y5 years | +590.4% | +670.1% |
CYTK Current liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +150.0% | -11.1% | +143.4% |
5 y | 5-year | at high | +590.4% | -11.1% | +670.1% |
alltime | all time | at high | +3812.8% | -11.1% | +3904.2% |
CYTK Current liabilities History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $159.73M(-11.1%) |
Dec 2024 | $179.67M(+75.0%) | $179.67M(+63.6%) |
Sep 2024 | - | $109.81M(+6.8%) |
Jun 2024 | - | $102.78M(+15.7%) |
Mar 2024 | - | $88.86M(-13.5%) |
Dec 2023 | $102.68M(+21.3%) | $102.68M(+32.1%) |
Sep 2023 | - | $77.72M(+18.4%) |
Jun 2023 | - | $65.62M(-12.8%) |
Mar 2023 | - | $75.22M(-11.1%) |
Dec 2022 | $84.62M(+17.8%) | $84.62M(+10.6%) |
Sep 2022 | - | $76.50M(+14.4%) |
Jun 2022 | - | $66.84M(-0.0%) |
Mar 2022 | - | $66.85M(-7.0%) |
Dec 2021 | $71.86M(+130.3%) | $71.86M(-11.1%) |
Sep 2021 | - | $80.87M(+30.9%) |
Jun 2021 | - | $61.77M(+71.9%) |
Mar 2021 | - | $35.93M(+15.2%) |
Dec 2020 | $31.20M(+19.9%) | $31.20M(+13.2%) |
Sep 2020 | - | $27.57M(+21.5%) |
Jun 2020 | - | $22.70M(+9.4%) |
Mar 2020 | - | $20.74M(-20.3%) |
Dec 2019 | $26.02M(+17.3%) | $26.02M(+20.9%) |
Sep 2019 | - | $21.52M(-2.0%) |
Jun 2019 | - | $21.96M(-16.4%) |
Mar 2019 | - | $26.28M(+18.4%) |
Dec 2018 | $22.19M(-31.6%) | $22.19M(+3.3%) |
Sep 2018 | - | $21.49M(-21.2%) |
Jun 2018 | - | $27.29M(-29.2%) |
Mar 2018 | - | $38.55M(+18.8%) |
Dec 2017 | $32.44M(-2.4%) | $32.44M(-23.4%) |
Sep 2017 | - | $42.36M(+36.4%) |
Jun 2017 | - | $31.06M(-15.6%) |
Mar 2017 | - | $36.80M(+10.6%) |
Dec 2016 | $33.26M(+5.1%) | $33.26M(+13.4%) |
Sep 2016 | - | $29.33M(+11.7%) |
Jun 2016 | - | $26.27M(+6.4%) |
Mar 2016 | - | $24.68M(-22.0%) |
Dec 2015 | $31.65M(+32.7%) | $31.65M(+5.0%) |
Sep 2015 | - | $30.14M(+3.5%) |
Jun 2015 | - | $29.11M(+14.7%) |
Mar 2015 | - | $25.39M(+6.4%) |
Dec 2014 | $23.86M | $23.86M(+83.7%) |
Sep 2014 | - | $12.99M(-23.2%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2014 | - | $16.92M(-14.5%) |
Mar 2014 | - | $19.79M(-25.9%) |
Dec 2013 | $26.70M(+275.8%) | $26.70M(-40.7%) |
Sep 2013 | - | $45.01M(+32.2%) |
Jun 2013 | - | $34.05M(+485.1%) |
Mar 2013 | - | $5.82M(-18.1%) |
Dec 2012 | $7.11M(+54.7%) | $7.11M(+54.8%) |
Sep 2012 | - | $4.59M(+15.0%) |
Jun 2012 | - | $3.99M(-10.7%) |
Mar 2012 | - | $4.47M(-2.7%) |
Dec 2011 | $4.59M(-37.3%) | $4.59M(-8.8%) |
Sep 2011 | - | $5.03M(-8.6%) |
Jun 2011 | - | $5.50M(-8.9%) |
Mar 2011 | - | $6.04M(-17.5%) |
Dec 2010 | $7.32M(-63.7%) | $7.32M(+12.9%) |
Sep 2010 | - | $6.49M(-5.6%) |
Jun 2010 | - | $6.88M(-60.8%) |
Mar 2010 | - | $17.53M(-13.1%) |
Dec 2009 | $20.19M(-11.8%) | $20.19M(-1.4%) |
Sep 2009 | - | $20.47M(-12.0%) |
Jun 2009 | - | $23.25M(+5.4%) |
Mar 2009 | - | $22.06M(-3.6%) |
Dec 2008 | $22.88M(-13.5%) | $22.88M(-6.5%) |
Sep 2008 | - | $24.47M(-1.9%) |
Jun 2008 | - | $24.95M(-5.1%) |
Mar 2008 | - | $26.29M(-0.6%) |
Dec 2007 | $26.45M(+0.2%) | $26.45M(+0.8%) |
Sep 2007 | - | $26.24M(+7.6%) |
Jun 2007 | - | $24.39M(+2.3%) |
Mar 2007 | - | $23.85M(-9.6%) |
Dec 2006 | $26.39M(+134.3%) | $26.39M(+112.8%) |
Sep 2006 | - | $12.40M(+16.5%) |
Jun 2006 | - | $10.65M(+10.0%) |
Mar 2006 | - | $9.69M(-14.0%) |
Dec 2005 | $11.26M(+2.0%) | $11.26M(+4.6%) |
Sep 2005 | - | $10.76M(+2.7%) |
Jun 2005 | - | $10.48M(-13.4%) |
Mar 2005 | - | $12.10M(+9.6%) |
Dec 2004 | $11.04M(+16.7%) | $11.04M(+2.3%) |
Sep 2004 | - | $10.79M(+3.1%) |
Jun 2004 | - | $10.47M(+13.4%) |
Mar 2004 | - | $9.23M(-2.4%) |
Dec 2003 | $9.46M(+0.9%) | $9.46M |
Dec 2002 | $9.38M | - |
FAQ
- What is Cytokinetics Incorporated annual total current liabilities?
- What is the all time high annual current liabilities for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated annual current liabilities year-on-year change?
- What is Cytokinetics Incorporated quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated quarterly current liabilities year-on-year change?
What is Cytokinetics Incorporated annual total current liabilities?
The current annual current liabilities of CYTK is $179.67M
What is the all time high annual current liabilities for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high annual total current liabilities is $179.67M
What is Cytokinetics Incorporated annual current liabilities year-on-year change?
Over the past year, CYTK annual total current liabilities has changed by +$77.00M (+74.99%)
What is Cytokinetics Incorporated quarterly total current liabilities?
The current quarterly current liabilities of CYTK is $159.73M
What is the all time high quarterly current liabilities for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high quarterly total current liabilities is $179.67M
What is Cytokinetics Incorporated quarterly current liabilities year-on-year change?
Over the past year, CYTK quarterly total current liabilities has changed by +$70.87M (+79.76%)